Follow The Filings

CNS Cohen & Steers Inc.

Financials, filed as COHEN & STEERS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 2 Owners
  • Max 0.0%
  • $12M
  • 1 add 1 reduce

In 2026 Q2 First Eagle Investment Management added to Cohen & Steers, while Ron Baron trimmed.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Ron Baron, Bamco Inc. (Baron Capital)). Not free-float ownership.

  1. Ron Baron Reduce 0.02%

Who owns CNS

Sorted by value, long equity only, as of 2026 Q2.

History
Ron Baron, Bamco Inc. (Baron Capital) 0.02%, was 0.03% Reduce −7.0% 153,511 $12M History
First Eagle Investment Management <0.01% Add +345.9% 272 $21K History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CNS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CNS insider trades
  • $14.3M bought by 2 insiders
  • $2.5M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Elena Dulik Chief Accounting Officer, SVP
    Sale
    $91K 1,100 shares at $83.16 4.7% of stake
    Traded Jul 20 Filed Jul 21
  2. Daniel Noonan Executive Vice President
    Sale
    $337K 4,360 shares at $77.33 100% of stake
    Traded Jun 16 Filed Jun 16
  3. Jon Cheigh President and CIO
    Sale
    $753K 10,500 shares at $71.75 14% of stake
    Traded May 26 Filed May 27
  4. Francis C Poli GC, Secretary, EVP
    Sale
    $1.3M 19,696 shares at $65.68 26% of stake
    Traded Feb 11–12 Filed Feb 12
  5. Robert Hamilton Steers Chair
    Buy
    $1.5M 25,000 shares at $59.88 +0.6% to stake
    Traded Nov 19, 2025 Filed Nov 20, 2025
  6. Martin Cohen Director
    Buy
    $6M 100,000 shares at $59.82 +12% to stake
    Traded Nov 18–20 Filed Nov 20, 2025
  7. Robert Hamilton Steers Chair
    Buy
    $6.9M 100,888 shares at $67.98 +1.4% to stake
    Traded Nov 3–5 Filed Nov 5, 2025
  8. Robert Hamilton Steers Chair
    Buy
    $2.8M 40,539 shares at $70.21 +1.1% to stake
    Traded Oct 20–22 Filed Oct 22, 2025

Also filed in the last 12 months, not counted as buying or selling: 70 stock grants, 10 share withholdings for taxes, and 10 gifts.

Congress

2 members of Congress traded CNS in the last three years: 1 buy and 1 sale. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Oct 30, 2025 filed Nov 18, 2025
  2. Josh Gottheimer D-NJ-5Joint Partial sale $1K–$15K Sep 25, 2024 filed Oct 3, 2024

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $489.64M $517.42M $556.12M
Net income $129.05M $151.26M $153.22M
Net margin * 26.4% 29.2% 27.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $736.55M $812.37M $876.69M
Total equity $381.23M $511.71M $561.95M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $171.96M $96.69M -$120.44M
Cash from investing -$114.78M -$119.71M $8.36M
Cash from financing -$119.05M $18.17M $73.84M
Net change in cash * -$61.87M -$4.86M -$38.25M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.